Cd13–/– mice treated with a B1R antagonist exhibited a reduction in arthritis development compared with WT mice, but a significant decrease in arthritis did not appear until day 8, suggesting the importance of both ligands of B1R in arthritis development in this model, bradykinin early and sCD13 later. This evidence concerns the gene BDKRB1 and Arthritis.